MIRM
Mirum Pharmaceuticals, Inc.Company with tickers: MIRM
CIK
1759425
CUSIP
604749101
Shares Outstanding
60,981,227
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $159,882,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $949,347,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Research & Development | — | ||||
| Operating Income | $-789,465,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-790,155,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-13.43 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-13.43 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |